Please assess the completion status of the following clinical trial:

Trial Title: Protection of Rectum From High Radiation Doses Using a Spacer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* prostate cancer patients with planned low-dose brachytherapy for the treatment of prostate cancer~Exclusion Criteria:~* not willing to participate this study

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: 78 Years
- Healthy Volunteers: f

Study Arms:
- Diluted spacer (Type: EXPERIMENTAL): Single dose of DuraSeal product with DuraSeal components diluted 1:1 in sterile saline injected between rectum and prostate
- Non-diluted spacer (Type: ACTIVE_COMPARATOR): Single dose of DuraSeal product injected between rectum and prostate

Based on this trial design, predict the completion outcome and termination type (if applicable).